Dentsply Sirona (XRAY) EBIAT (2016 - 2025)
Dentsply Sirona (XRAY) has disclosed EBIAT for 17 consecutive years, with -$146.0 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, EBIAT rose 66.05% year-over-year to -$146.0 million, compared with a TTM value of -$598.0 million through Dec 2025, up 34.36%, and an annual FY2025 reading of -$598.0 million, up 34.29% over the prior year.
- EBIAT was -$146.0 million for Q4 2025 at Dentsply Sirona, up from -$427.0 million in the prior quarter.
- Across five years, EBIAT topped out at $119.0 million in Q4 2021 and bottomed at -$1.1 billion in Q3 2022.
- Average EBIAT over 5 years is -$109.0 million, with a median of $6.5 million recorded in 2024.
- The sharpest move saw EBIAT tumbled 1382.14% in 2022, then soared 546.67% in 2023.
- Year by year, EBIAT stood at $119.0 million in 2021, then plummeted by 112.61% to -$15.0 million in 2022, then skyrocketed by 546.67% to $67.0 million in 2023, then tumbled by 741.79% to -$430.0 million in 2024, then surged by 66.05% to -$146.0 million in 2025.
- Business Quant data shows EBIAT for XRAY at -$146.0 million in Q4 2025, -$427.0 million in Q3 2025, and -$44.0 million in Q2 2025.